Sentynl Therapeutics, Inc.
Records under this name other than the patents Sentynl Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 1 of 1 · Back to Sentynl Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,504,095 | Method for Obtaining Precursor Z and Use Thereof for the Production of a Means for Therapy of Human Molybdenum Cofactor Deficiency Term ended Term ended Jan 31, 2025 · High confidence | Term ended | Term ended Jan 31, 2025 | High confidence |